Jiang cstonepharma.com
WebCStone is a biopharmaceutical company that develops and commercializes drugs to treat immuno-oncology diseases. Cstone Pharmaceuticals was founded in 2015. Cstone Pharmaceuticals' headquarters is located in Shanghai, Shanghai Municipality, CN 201203. ... See more CEO Web10 apr. 2024 · Following its recent NDA approval in 2nd line NSCLC in China, the specific Ret inhibitor pralsetinib’s second NDA was accepted for priority review on April…
Jiang cstonepharma.com
Did you know?
Web14 mei 2024 · SUZHOU, China, May 14, 2024 /PRNewswire/ -- CStone Pharmaceuticals(CStone) today announced dosing of the first patient in a Phase I clinical trial in Australia for CS1003, an investigational anti-programmed death-1 (PD-1) monoclonal antibody (mAb). The open-label, first-in-human (FIH) study is initiated at Scientia Clinical …
Web24 jan. 2024 · CStone Pharmaceuticals (HKEX:2616) is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of... Webwww.cstonepharma.com REGISTERED OFFICE The offices of Vistra (Cayman) Limited P.O. Box 31119, Grand Pavilion Hibiscus Way 802 West Bay Road Grand Cayman KY1 …
Web26 feb. 2024 · HONG KONG, Feb. 26, 2024 /PRNewswire/ -- CStone Pharmaceuticals (Stock code: 2616) today announced the listing of 186,396,000 shares on the Main Board of the Hong Kong Stock Exchange. The net proceeds the Company receives from this offering will mainly be allocated to fund the Company's Core Product Candidate, clinical … Web28 okt. 2024 · Frank Jiang, M.D., Ph.D., Chairman and Chief Executive Officer of CStone, said: "We are very pleased to form this partnership with LCB, a leading ADC platform company, to obtain global rights to...
Web7 jun. 2024 · Jiang, in his 60s, is one of the founders of the company and became CEO in July 2016 and chairman in August 2024. He has been the vice global chairman of Sanofi ( SNY) and head of R&D at its Asia...
WebCStone Pharmaceuticals 6,317 followers on LinkedIn. 拓新药时代，筑健康基石 Lead the Era of Drug Innovation, Be the Cornerstone of Health CStone (HKEX: 2616) is a … rachel hargrove twitterWeb30 sep. 2024 · CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and... rachel harlow schalkWeb30 sep. 2024 · CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the … shoe shops in canterbury city centreWebSECURITY INFORMATION. Whenever you download a file over the Internet, there is always a risk that it will contain a security threat (a virus or a program that can damage … rachel harlestonWeb24 jan. 2024 · SUZHOU, China, Jan. 24, 2024 /PRNewswire/ --CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) recently announced that it has dosed the first patient in Australia in a clinical trial of CS1001, an investigational PD-L1 inhibitor developed by CStone, in combination with regorafenib, an oral multi-kinase inhibitor developed by … shoe shops in canadaWeb28 okt. 2024 · Frank Jiang, M.D., Ph.D., Chairman and Chief Executive Officer of CStone, said: "We are very pleased to form this partnership with LCB, a leading ADC platform company, to obtain global rights to an asset with highly differentiated attributes in an exciting new field of oncology. rachel harlow schalk bozemanWeb27 feb. 2024 · As Dr. Frank Ningjun Jiang, M.D., Ph.D., the Executive Director, Chairman and CEO of CStone Pharmaceuticals, indicated, "The IPO debut in Hong Kong marks a … rachel harmon express scripts